Endocrinology, Vol 135, 2454-2458, Copyright © 1994 by Endocrine Society

ARTICLES

Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells

S Eguchi, Y Hirata, H Iwasaki, K Sato, TX Watanabe, T Inui, K Nakajima, S Sakakibara and F Marumo
Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.

Vascular smooth muscle cells (VSMC) from rat aorta possess specific receptors for a novel potent vasorelaxant peptide, adrenomedullin (AM). To elucidate its receptor coupling to guanine nucleotide-binding stimulatory protein and the structural requirement of the AM molecule to its vascular receptors, we have studied the effects of guanine nucleotides on [125I]human (h) AM binding and adenylate cyclase activity in cultured rat VSMC, and the effects of various synthetic hAM analogs on [125I]hAM binding and the cAMP response. Guanosine 5'-O-(3- thiotriphosphate) dose dependently inhibited [125I]hAM binding to rat VSMC membranes. hAM stimulated adenylate cyclase activity, and its effect was additive with GTP. hAM-induced cAMP formation was abrogated by pretreatment with cholera toxin, but not by that with pertussis toxin. Intact hAM-(1-52)-NH2 and N-terminal truncated derivatives [hAM- (13-52)-NH2, hAM-(16-52)-NH2] almost equally inhibited [125I]hAM binding and stimulated cAMP formation, whereas removal of C-terminal Tyr52 residue [hAM-(1-51)-NH2] remarkably decreased receptor-binding activity and the cAMP response. The effects of hAM-(1-52)-OH, hAM-(1- 51)-OH, and a linear hAM analog ([carbamoylmethyl-Cys16,21]hAM-NH2) were far less potent on receptor binding and the cAMP response than that of hAM-(1-52)-NH2. The C-terminal fragment [hAM-(33-52)-NH2] and the N-terminal fragment [hAM-(1-10)-OH] had neither receptor-binding nor adenylate cyclase activity. hAM-(22-52)-NH2 had no agonistic effect, but showed an antagonistic effect on the hAM-induced cAMP response. These data suggest that vascular AM receptors are functionally coupled to adenylate cyclase via guanine nucleotide- binding stimulatory protein. Studies of the structure-activity relationship of hAM revealed that the cyclic structure formed by the disulfide bridge and amidation of the C-terminal residue of the AM molecule are critical for receptor binding and subsequent cAMP generation and suggest that the C-terminal fragment hAM-(22-52)-NH2 may be an antagonist for vascular AM receptors.

This article has been cited by other articles:

				Y.-Y. Li, L. Li, I. S.-S. Hwang, F. Tang, and W.-S. O Coexpression of Adrenomedullin and Its Receptors in the Reproductive System of the Rat: Effects on Steroid Secretion in Rat Ovary Biol Reprod, August 1, 2008; 79(2): 200 - 208. [Abstract] [Full Text] [PDF]

				F. Wunder, A. Rebmann, A. Geerts, and B. Kalthof Pharmacological and Kinetic Characterization of Adrenomedullin 1 and Calcitonin Gene-Related Peptide 1 Receptor Reporter Cell Lines Mol. Pharmacol., April 1, 2008; 73(4): 1235 - 1243. [Abstract] [Full Text] [PDF]

				Y.-Y. Li, W.-S. O, and F. Tang Effect of Aging on the Expression of Adrenomedullin and Its Receptor Component Proteins in the Male Reproductive System of the Rat J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2007; 62(12): 1346 - 1351. [Abstract] [Full Text] [PDF]

				Y.-Y. Li, I. S.-S. Hwang, W.-S. O, and F. Tang Adrenomedullin Peptide: Gene Expression of Adrenomedullin, its Receptors and Receptor Activity Modifying Proteins, and Receptor Binding in Rat Testis--Actions on Testosterone Secretion Biol Reprod, August 1, 2006; 75(2): 183 - 188. [Abstract] [Full Text] [PDF]

				C.W. Tam, K. Husmann, N.C. Clark, J.E. Clark, Z. Lazar, L.M. Ittner, J. Gotz, G. Douglas, A.D. Grant, D. Sugden, et al. Enhanced Vascular Responses to Adrenomedullin in Mice Overexpressing Receptor-Activity-Modifying Protein 2 Circ. Res., February 3, 2006; 98(2): 262 - 270. [Abstract] [Full Text] [PDF]

				S. D. Brain and A. D. Grant Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin Physiol Rev, July 1, 2004; 84(3): 903 - 934. [Abstract] [Full Text] [PDF]

				J. Roh, C. L. Chang, A. Bhalla, C. Klein, and S. Y. T. Hsu Intermedin Is a Calcitonin/Calcitonin Gene-related Peptide Family Peptide Acting through the Calcitonin Receptor-like Receptor/Receptor Activity-modifying Protein Receptor Complexes J. Biol. Chem., February 20, 2004; 279(8): 7264 - 7274. [Abstract] [Full Text] [PDF]

				G. M. Kravtsov, I. S. S. Hwang, and F. Tang The Inhibitory Effect of Adrenomedullin in the Rat Ileum: Cross-Talk with {beta}3-Adrenoceptor in the Serotonin-Induced Muscle Contraction J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 241 - 248. [Abstract] [Full Text] [PDF]

				M. Zhou, Z. F. Ba, I. H. Chaudry, and P. Wang Adrenomedullin binding protein-1 modulates vascular responsiveness to adrenomedullin in late sepsis Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R553 - R560. [Abstract] [Full Text] [PDF]

				H. Nishimatsu, Y. Hirata, T. Shindo, H. Kurihara, M. Kakoki, D. Nagata, H. Hayakawa, H. Satonaka, M. Sata, A. Tojo, et al. Role of Endogenous Adrenomedullin in the Regulation of Vascular Tone and Ischemic Renal Injury: Studies on Transgenic/Knockout Mice of Adrenomedullin Gene Circ. Res., April 5, 2002; 90(6): 657 - 663. [Abstract] [Full Text] [PDF]

				K Tambara, M Fujita, N Nagaya, S Miyamoto, A Iwakura, K Doi, G Sakaguchi, K Nishimura, K Kangawa, and M Komeda Increased pericardial fluid concentrations of the mature form of adrenomedullin in patients with cardiac remodelling Heart, March 1, 2002; 87(3): 242 - 246. [Abstract] [Full Text] [PDF]

				T. Tokura, H. Kinoshita, S. Fujimoto, S. Hisanaga, K. Kitamura, and T. Eto Plasma levels of mature form of adrenomedullin in patients with haemodialysis Nephrol. Dial. Transplant., April 1, 2001; 16(4): 783 - 786. [Abstract] [Full Text] [PDF]

				V. Santiemma, F. Rossi, L. Guerrini, A. Markouizou, G. Pasimeni, S. Palleschi, and A. Fabbrini Adrenomedullin Inhibits the Contraction of Cultured Rat Testicular Peritubular Myoid Cells Induced by Endothelin-1 Biol Reprod, February 1, 2001; 64(2): 619 - 624. [Abstract] [Full Text]

				K. Terata, H. Miura, Y. Liu, F. Loberiza, and D. D. Gutterman Human coronary arteriolar dilation to adrenomedullin: role of nitric oxide and K+ channels Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2620 - H2626. [Abstract] [Full Text] [PDF]

				J. P. Hinson, S. Kapas, and D. M. Smith Adrenomedullin, a Multifunctional Regulatory Peptide Endocr. Rev., April 1, 2000; 21(2): 138 - 167. [Abstract] [Full Text]

				T. Tsuruda, J. Kato, K. Kitamura, M. Kawamoto, K. Kuwasako, T. Imamura, Y. Koiwaya, T. Tsuji, K. Kangawa, and T. Eto An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth Cardiovasc Res, September 1, 1999; 43(4): 958 - 967. [Abstract] [Full Text] [PDF]

				N. Bühlmann, K. Leuthäuser, R. Muff, J. A. Fischer, and W. Born A Receptor Activity Modifying Protein (RAMP)2-Dependent Adrenomedullin Receptor Is a Calcitonin Gene-Related Peptide Receptor when Coexpressed with Human RAMP1 Endocrinology, June 1, 1999; 140(6): 2883 - 2890. [Abstract] [Full Text]

				E. B. Pewitt, R. Haleem, and Z. Wang Adrenomedullin Gene Is Abundantly Expressed and Directly Regulated by Androgen in the Rat Ventral Prostate Endocrinology, May 1, 1999; 140(5): 2382 - 2386. [Abstract] [Full Text]

				K. Masada, T. Nagayama, A. Hosokawa, M. Yoshida, M. Suzuki-Kusaba, H. Hisa, T. Kimura, and S. Satoh Effects of adrenomedullin and PAMP on adrenal catecholamine release in dogs Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1999; 276(4): R1118 - R1124. [Abstract] [Full Text] [PDF]

				H. Hayakawa, Y. Hirata, M. Kakoki, Y. Suzuki, H. Nishimatsu, D. Nagata, E. Suzuki, K. Kikuchi, T. Nagano, K. Kangawa, et al. Role of Nitric Oxide–cGMP Pathway in Adrenomedullin-Induced Vasodilation in the Rat Hypertension, February 1, 1999; 33(2): 689 - 693. [Abstract] [Full Text] [PDF]

				P. Wang, Z. F. Ba, W. G. Cioffi, K. I. Bland, and I. H. Chaudry The Pivotal Role of Adrenomedullin in Producing Hyperdynamic Circulation During the Early Stage of Sepsis Arch Surg, December 1, 1998; 133(12): 1298 - 1304. [Abstract] [Full Text] [PDF]

				H. Iwasaki, S. Eguchi, M. Shichiri, F. Marumo, and Y. Hirata Adrenomedullin as a Novel Growth-Promoting Factor for Cultured Vascular Smooth Muscle Cells: Role of Tyrosine Kinase-Mediated Mitogen-Activated Protein Kinase Activation Endocrinology, August 1, 1998; 139(8): 3432 - 3441. [Abstract] [Full Text] [PDF]

				Y. Isumi, N. Minamino, T. Katafuchi, M. Yoshioka, T. Tsuji, K. Kangawa, and H. Matsuo Adrenomedullin Production in Fibroblasts: Its Possible Function as a Growth Regulator of Swiss 3T3 Cells Endocrinology, May 1, 1998; 139(5): 2552 - 2563. [Abstract] [Full Text] [PDF]

				M. Saita, A. Shimokawa, T. Kunitake, K. Kato, T. Hanamori, K. Kitamura, T. Eto, and H. Kannan Central actions of adrenomedullin on cardiovascular parameters and sympathetic outflow in conscious rats Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1998; 274(4): R979 - R984. [Abstract] [Full Text] [PDF]

				B. Gumusel, Q. Hao, A. L. Hyman, P. J. Kadowitz, H. C. Champion, J. K. Chang, J. L. Mehta, and H. Lippton Analysis of responses to adrenomedullin-(13---52) in the pulmonary vascular bed of rats Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1255 - H1263. [Abstract] [Full Text] [PDF]

				T. Tsuruda, J. Kato, K. Kitamura, K. Kuwasako, T. Imamura, Y. Koiwaya, T. Tsuji, K. Kangawa, and T. Eto Adrenomedullin: A Possible Autocrine or Paracrine Inhibitor of Hypertrophy of Cardiomyocytes Hypertension, January 1, 1998; 31(1): 505 - 510. [Abstract] [Full Text] [PDF]

				J. Cornish, K. E. Callon, D. H. Coy, N.-Y. Jiang, L. Xiao, G. J. S. Cooper, and I. R. Reid Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo Am J Physiol Endocrinol Metab, December 1, 1997; 273(6): E1113 - E1120. [Abstract] [Full Text] [PDF]

				M. Nakamura, H. Yoshida, S. Makita, N. Arakawa, H. Niinuma, and K. Hiramori Potent and Long-Lasting Vasodilatory Effects of Adrenomedullin in Humans: Comparisons Between Normal Subjects and Patients With Chronic Heart Failure Circulation, March 4, 1997; 95(5): 1214 - 1221. [Abstract] [Full Text]

				A. Martinez, M. J. Miller, K. J. Catt, and F. Cuttitta Adrenomedullin Receptor Expression in Human Lung and in Pulmonary Tumors J. Histochem. Cytochem., February 1, 1997; 45(2): 159 - 164. [Abstract] [Full Text] [PDF]

				K. Meeran, D. O'Shea, P. D. Upton, C. J. Small, M. A. Ghatei, P. H. Byfield, and S. R. Bloom Circulating Adrenomedullin Does Not Regulate Systemic Blood Pressure but Increases Plasma Prolactin after Intravenous Infusion in Humans: A Pharmacokinetic Study J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 95 - 100. [Abstract] [Full Text] [PDF]

				H. C. Champion, R. C. Fry, W. A. Murphy, D. H. Coy, and P. J. Kadowitz Catecholamine Release Mediates Pressor Effects of Adrenomedullin-(15-22) in the Rat Hypertension, December 1, 1996; 28(6): 1041 - 1046. [Abstract] [Full Text]

				S. Kapas, K. J. Catt, and A. J. L. Clark Cloning and Expression of cDNA Encoding a Rat Adrenomedullin Receptor J. Biol. Chem., October 27, 1995; 270(43): 25344 - 25347. [Abstract] [Full Text] [PDF]

				K. Kuwasako, K. Kitamura, K. Ito, T. Uemura, Y. Yanagita, J. Kato, T. Sakata, and T. Eto The Seven Amino Acids of Human RAMP2 (86) and RAMP3 (59) Are Critical for Agonist Binding to Human Adrenomedullin Receptors J. Biol. Chem., December 21, 2001; 276(52): 49459 - 49465. [Abstract] [Full Text] [PDF]

				H. Nishimatsu, Y. Hirata, T. Shindo, H. Kurihara, M. Kakoki, D. Nagata, H. Hayakawa, H. Satonaka, M. Sata, A. Tojo, et al. Role of Endogenous Adrenomedullin in the Regulation of Vascular Tone and Ischemic Renal Injury: Studies on Transgenic/Knockout Mice of Adrenomedullin Gene Circ. Res., April 5, 2002; 90(6): 657 - 663. [Abstract] [Full Text] [PDF]